Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
about the author
Amber Tong
amber@endpointsnews.com
@AmberTongPW
Amber Tong on LinkedIn
author articles
Mayo Clinic launches clinical analytics platform with nference; WuXi buys German plant from Bayer
6 years ago
News Briefing
Frazier closes 12th fund in 30 years, with $617M to bet on cell/gene therapy, Big Pharma spinoffs and more
6 years ago
Financing
Biopharma's China plan gets a boost from patent protections sealed in now official trade deal
6 years ago
China
FDA+
Celgene exec jumps to head bluebird bio ops in Europe, where its $1.8M gene therapy Zynteglo is now available
6 years ago
People
Takeda hops onto $61M round for CRISPR player synthesizing Cas9 alternatives
6 years ago
Financing
Startups
Galapagos beefs up its fibrosis pipeline, lassoing 4 more programs and taking a stake in small Canadian partner
6 years ago
Deals
Four years after 'moonshot' launch, Patrick Soon-Shiong has a big reveal: a single patient
6 years ago
R&D
Roche aims to 'underwhelm' with risdiplam price as it enters SMA rivalry with Biogen, Novartis — report
6 years ago
Pharma
Gates vets at Adjuvant back Codagenix's software-driven approach to recoding RSV, flu, oncolytic viruses and more
6 years ago
Financing
Startups
Ahead of aducanumab filing, Biogen nabs Pfizer castoff for $75M to address Alzheimer's, Parkinson's symptoms
6 years ago
Deals
Shooting for $100M IPO, Schrödinger takes the wraps off its five internal drugs and discloses deal details
6 years ago
Financing
RA Capital, Canaan help infuse $50M into Alta-incubated biotech battling acquired resistance to TKIs
6 years ago
Financing
Startups
23andMe finds a buyer for its IL-36 bispecific in Almirall; Neurocrine, Idorsia revise epilepsy drug deal
6 years ago
News Briefing
What are biopharma companies hiring CROs for these days? PPD spells it out in bid for $100M IPO
6 years ago
Financing
Outsourcing
Blackstone plots $4.5B+ life sciences fund — and they've already secured the bulk of it
6 years ago
Financing
Eyeing the 'translatome,' Pfizer ties another knot with biotech partner for preclinical, next-gen targeted therapies
6 years ago
Deals
ADC Therapeutics clears a big hurdle toward its first BLA as pivotal PhII delivers upbeat ORR results
6 years ago
R&D
Boehringer Ingelheim inks 'Singapore's largest biotech deal,' promising $1B each for a suite of anti-fibrotic IL-11 ...
6 years ago
Deals
Mark Alles begins his post-Celgene career on the board of a US-China biotech led by a former colleague
6 years ago
R&D
WuXi-backed Adagene scores $69M round led by General Atlantic to push antibodies where Bristol-Myers struggled
6 years ago
Financing
China
A for augmented: Cambridge AI company out to capture biomedical knowledge gets $60M from Mayo, Silicon Valley VC
6 years ago
Financing
AI
'Burner' phones and Ariad secrets: Goldman Sachs banker pleads guilty for his role in global insider trading ring
6 years ago
People
FDA+
SpaceX investor backs Toronto AI upstart's journey into the 'dark region' of genetic diseases
6 years ago
Financing
AI
Fresh from $94.5M crossover round, Frazier-groomed dermatology biotech shoots for $100M IPO
6 years ago
Financing
First page
Previous page
83
84
85
86
87
88
89
Next page
Last page
